Join to View Full Profile
120 Mineola BoulevardSuite 500Mineola, NY 11501
Dr. Braunstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board-certified adult hematologist/oncologist with focus on hematologic malignancies, and a research interest in multiple myeloma. I see patients with both benign and malignant hematologic conditions and make it a point to tailor therapy to individual patients' needs.
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2014 - 2017
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2011 - 2014
State University of New York Downstate Medical Center College of MedicineClass of 2010
Certifications & Licensure
NY State Medical License 2012 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A plain language summary of the CEPHEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for people with newly diagnosed multiple myeloma who are ...Saad Z Usmani, Thierry Facon, Vania Hungria, Nizar J Bahlis, Christopher P Venner
Future Oncology. 2025-10-01 - 1 citationsA multiomic analysis of Waldenström macroglobulinemia defines distinct disease subtypes.Dylan C Gagler, Hussein Ghamlouch, Di Zhang, Patrick Blaney, Avital Tenenbaum
Blood. 2025-09-04 - 4 citationsAuthor Correction: Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the r...Saad Z Usmani, Thierry Facon, Vania Hungria, Nizar J Bahlis, Christopher P Venner
Nature Medicine. 2025-04-01
Abstracts/Posters
- Analysis of Intestinal Microbiome in Multiple Myeloma Reveals Progressive Dysbiosis Compared to MGUS and Healthy IndividualsMarc Braunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Retrospective Assessment of Outcomes Following Superficial Vein Thrombosis in Cancer PatientsMarc Braunstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Authored Content
- ASH 2022 Abstract Previews: Novel Immunotherapies for Multiple MyelomaDecember 2022
Press Mentions
Try This New Technique When Talking to Vaccine SkepticsAugust 7th, 2021- My New Normal Moral InjuryJuly 31st, 2020
uBiome Awards Groundbreaking Grant to Investigators at NYU Winthrop Hospital to Study Gut Dysbiosis Signatures in Multiple Myeloma PatientsNovember 13th, 2018- Join now to see all
Committees
- Co-Director of the Hematology/Oncology curriulum, NYU Winthrop Medical School Curriculum Committee 2017 - 2018
Research History
- Postdoctoral fellowI examined the role of the host immune system in the pathogenesis of multiple myeloma.2015 - 2017
- Graduate studentI examined the role of the microenvironment in the pathogenesis of multiple myeloma2004 - 2009
Professional Memberships
- Member
- Member
- Member
External Links
- NYU Winthrop Sitehttps://doctors.winthrop.org/details/23873/marc-braunstein-hematology_oncology-mineola
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
